Fig. 9From: Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS databaseRegression analysis of the risk of hospitalization due to serious adverse events associated with ADC drugsBack to article page